DOX(DOX)
DOX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $4.70B | $4.87B | $5.08B | $5.28B | $5.49B |
| Low | $4.66B | $4.83B | $5.06B | $5.25B | $5.46B |
| High | $4.71B | $4.89B | $5.10B | $5.30B | $5.51B |
| EBITDA Avg | $922M | $955M | $997M | $1.04B | $1.08B |
| Low | $915M | $948M | $994M | $1.03B | $1.07B |
| High | $925M | $959M | $1.00B | $1.04B | $1.08B |
| EBIT Avg | $715M | $741M | $774M | $805M | $837M |
| Low | $710M | $736M | $771M | $799M | $831M |
| High | $718M | $744M | $776M | $808M | $840M |
| Net Income Avg | $828M | $900M | $1.02B | $1.13B | $1.24B |
| Low | $826M | $885M | $1.01B | $1.12B | $1.23B |
| High | $830M | $915M | $1.02B | $1.13B | $1.25B |
| EPS Avg | $7.41 | $8.06 | $9.13 | $10.09 | $11.14 |
| Low | $7.39 | $7.92 | $9.05 | $10.00 | $11.04 |
| High | $7.43 | $8.19 | $9.17 | $10.14 | $11.19 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 4 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $1.19B | $1.20B | $1.21B | $1.21B | $1.24B |
| Low | $1.18B | $1.19B | $1.21B | $1.20B | $1.23B |
| High | $1.20B | $1.21B | $1.22B | $1.22B | $1.25B |
| EBITDA Avg | $234M | $236M | $238M | $237M | $243M |
| Low | $233M | $234M | $237M | $235M | $241M |
| High | $236M | $237M | $240M | $238M | $244M |
| EBIT Avg | $182M | $183M | $185M | $184M | $188M |
| Low | $180M | $182M | $184M | $182M | $187M |
| High | $183M | $184M | $186M | $185M | $190M |
| Net Income Avg | $212M | $210M | $212M | $213M | $222M |
| Low | $210M | $208M | $210M | $211M | $220M |
| High | $216M | $212M | $214M | $215M | $224M |
| EPS Avg | $1.98 | $1.96 | $1.98 | $1.98 | $2.06 |
| Low | $1.96 | $1.94 | $1.96 | $1.96 | $2.04 |
| High | $2.01 | $1.98 | $1.99 | $2.00 | $2.08 |
| Analysts (Rev / EPS) | 4 / 4 | 3 / 2 | 3 / 2 | 2 / 1 | 2 / 1 |